New Zealand markets closed

Guardant Health, Inc. (GH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
17.35+0.19 (+1.11%)
At close: 04:00PM EDT
17.57 +0.22 (+1.27%)
After hours: 05:45PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.11B
Enterprise value 2.30B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.45
Price/book (mrq)13.31
Enterprise value/revenue 4.07
Enterprise value/EBITDA -5.30

Trading information

Stock price history

Beta (5Y monthly) 0.90
52-week change 3-22.92%
S&P500 52-week change 322.36%
52-week high 341.06
52-week low 315.81
50-day moving average 318.77
200-day moving average 326.38

Share statistics

Avg vol (3-month) 31.97M
Avg vol (10-day) 31.8M
Shares outstanding 5121.71M
Implied shares outstanding 6121.71M
Float 8109.64M
% held by insiders 14.15%
% held by institutions 193.29%
Shares short (15 Apr 2024) 49.56M
Short ratio (15 Apr 2024) 43.93
Short % of float (15 Apr 2024) 48.18%
Short % of shares outstanding (15 Apr 2024) 47.85%
Shares short (prior month 15 Mar 2024) 47.76M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -85.02%
Operating margin (ttm)-73.42%

Management effectiveness

Return on assets (ttm)-17.64%
Return on equity (ttm)-438.12%

Income statement

Revenue (ttm)563.95M
Revenue per share (ttm)5.04
Quarterly revenue growth (yoy)22.20%
Gross profit (ttm)N/A
EBITDA -436.34M
Net income avi to common (ttm)-479.45M
Diluted EPS (ttm)-4.28
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.17B
Total cash per share (mrq)9.6
Total debt (mrq)1.35B
Total debt/equity (mrq)853.12%
Current ratio (mrq)6.54
Book value per share (mrq)1.30

Cash flow statement

Operating cash flow (ttm)-324.98M
Levered free cash flow (ttm)-176.88M